-+ 0.00%
-+ 0.00%
-+ 0.00%

AlzeCure Pharma Appoints Chief Scientific Officer as Acting CEO

MT Newswires·10/28/2026 01:18:07
Listen to the news
01:18 AM EDT, 10/28/2026 (MT Newswires) -- AlzeCure Pharma (ALZCUR.ST) named Chief Scientific Officer Johan Sandin as acting chief executive officer, effective Tuesday, according to a same-day release. Sandin's appointment follows the planned departure of CEO Martin Jönsson, the Swedish biotech company said. The search process for a permanent successor will be launched. Meanwhile, head of discovery and research Pontus Forsell will assume the deputy CEO role.